Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
British Journal of Haematology|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual diseaseMiguel Alcoceba, James P Stewart, María García-Álvarez, et al.Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|August 5, 2015
[Antihistamines for the treatment of urticaria in Mexico]Désirée Larenas-Linnemann, Mario Sánchez-Borges, Blanca Estela Del Río-Navarro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialEva Giné, Fátima de la Cruz, Ana Jiménez Ubieto, et al.Blood Cancer Journal|February 8, 2020
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patientsAlejandro Medina, Cristina Jiménez, M Eugenia Sarasquete, et al.Blood Cancer Journal|October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myelomaAlejandro Medina, Noemi Puig, Juan Flores-Montero, et al.Leukemia|November 3, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trialMouhamad Khouja, Elisa Genuardi, Simone Ferrero, et al.British Journal of Haematology|May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53)Miguel Bastos-Boente, Alejandro Medina-Herrera, Almudena Navarro-Bailón, et al.Journal of Clinical Immunology|June 11, 2021
COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from MexicoLina M Castano-Jaramillo, Marco Antonio Yamazaki-Nakashimada, Patricia M O'Farrill-Romanillos, et al.Cancers|October 27, 2022
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical TrialJuan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, et al.Blood Cancer Discovery|March 11, 2026
Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancersCarmen González, Juan-Jose Garces, Hector Gracia, et al.Pageof 10